(19)
(11)EP 1 878 743 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
28.05.2008 Bulletin 2008/22

(43)Date of publication A2:
16.01.2008 Bulletin 2008/03

(21)Application number: 07015706.0

(22)Date of filing:  19.10.2001
(51)Int. Cl.: 
C07K 14/575  (2006.01)
A61K 38/22  (2006.01)
C07K 7/52  (2006.01)
A61K 38/12  (2006.01)
(84)Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
LT

(30)Priority: 20.10.2000 US 241896 P

(62)Application number of the earlier application in accordance with Art. 76 EPC:
01987763.8 / 1355940

(71)Applicants:
  • The Administrators of The Tulane Educational Fund
    New Orleans Louisiana 70112 (US)
  • SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S.
    75016 Paris (FR)

(72)Inventors:
  • Coy, David H.
    New Orleans LA 70103 (US)
  • Rossowski, Wojciech, J.
    Kenner LA 70065 (US)
  • Taylor, John E.
    Upton MA 01568 (US)

(74)Representative: Taylor, Kate Laura et al
Harrison Goddard Foote 106 Micklegate
York YO1 6JX
York YO1 6JX (GB)

  


(54)Urotensin-II agonists and antagonists


(57) The present invention features a novel class of cyclic polypeptides that have U-II antagonist and agonist activity. The invention also features methods for treating physiological or psychological conditions characterized by an excess or under expression of Urotensin-II.